日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial

ACCORD试验中胰岛素剂量与心血管死亡率的关系

Siraj, Elias S; Rubin, Daniel J; Riddle, Matthew C; Miller, Michael E; Hsu, Fang-Chi; Ismail-Beigi, Faramarz; Chen, Shyh-Huei; Ambrosius, Walter T; Thomas, Abraham; Bestermann, William; Buse, John B; Genuth, Saul; Joyce, Carol; Kovacs, Christopher S; O'Connor, Patrick J; Sigal, Ronald J; Solomon, Sol

The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report

COSEHC™全球血管风险管理质量改进计划:首次后续报告

Ferrario, Carlos M; Joyner, Janae; Colby, Chris; Exuzides, Alex; Moore, Michael; Simmons, Debra; Bestermann, William Jr; Frech-Tamas, Feride

The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes

ADMA-二甲双胍假说:代谢综合征和2型糖尿病心血管后果的关联

Bestermann, William H Jr

COSEHC global vascular risk management quality improvement program: rationale and design

COSEHC全球血管风险管理质量改进计划:原理和设计

Ferrario, Carlos M; Moore, Michael A; Bestermann, William Jr; Colby, Chris; Exuzides, Alex; Simmons, Debra; Panjabi, Sumeet

The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study

单片钙通道阻滞剂/他汀类药物联合治疗高血压和血脂异常:一项随机、安慰剂对照、多中心研究

Neutel, Joel M; Bestermann, William H; Dyess, Eric M; Graff, Alan; Kursun, Attila; Sutradhar, Santosh; Yunis, Carla